PG
AMED

PEAK6 Group’s Amedisys AMED Stock Holding History

PEAK6 Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-300
Closed -$13K – 4247
2016
Q4 		$13K Sell
300
-15,000
-98% -$638K ﹤0.01% 4494
2016
Q3 		$726K Sell
15,300
-2,800
-15% -$140K 0.01% 2042
2016
Q2 		$914K Buy
+18,100
New +$914K 0.01% 1871
2015
Q4 		– Sell
-3,100
Closed -$118K – 4685
2015
Q3 		$118K Sell
3,100
-50,200
-94% -$2.12M ﹤0.01% 4189
2015
Q2 		$2.12M Buy
+53,300
New +$1.66M 0.01% 1428
2015
Q1 		– Sell
-18,800
Closed -$552K – 4703
2014
Q4 		$552K Buy
18,800
+13,700
+269% +$338K ﹤0.01% 2505
2014
Q3 		$103K Buy
+5,100
New +$98.4K ﹤0.01% 3781
2013
Q4 		– Sell
-200,000
Closed -$1.72M – 4847
2013
Q3 		$1.72M Buy
+200,000
New +$2.97M 0.01% 1665

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Group's AMED Position: Q3 2017 in Review

PEAK6 Group sold out of Amedisys (AMED) in Q3 2017, closing a stake of 2,558 shares — an estimated $135K sold.

PEAK6 Group first reported a position in AMED in Q3 2013 and held it in 3 quarters. The position peaked at $550K in Q4 2016. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

  • PEAK6 Group reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 2,558 Amedisys shares in Q3 2017, an estimated $135K.
  • PEAK6 Group first reported a position in Amedisys in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Amedisys position peaked at $550K in Q4 2016.
  • 163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.